ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0494

Usefulness of the Neutrophil-to-Lymphocyte Ratio, the Platelet-to-Lymphocyte Ratio and the Systemic Immune Inflammatory Index in Assessing Disease Activity in Rheumatoid Arthritis Patients

Yelitza Cecilia Velarde Mejia1, Ventura Mejia2, guillermo velarde2 and Graciela Alarcon3, 1Hncase, Arequipa, Peru, 2UNIVERSIDAD NACIONAL DE SAN AGUSTIN, arequipa, Peru, 3The University of Alabama at Birmingham, Oakland, CA

Meeting: ACR Convergence 2024

Keywords: Biomarkers, Inflammation, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: RA – Diagnosis, Manifestations, & Outcomes Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Rheumatoid arthritis (RA) causes systemic inflammation that leads to specific changes in the patients’ blood cells; this offers the opportunity to measure inflammatory activity in these patients. Three indices that can be used to this end are: 1. the neutrophil-to-lymphocyte ratio (NLR), 2. the platelet-to-lymphocyte ratio (PLR) and the systemic immune inflammatory index (SIII). These ratios are easy to measure, reproducible, and cost-effective markers of inflammation. They can provide guidance for making treatment decisions on these patients

Methods: One-hundred and ninety RA patients who met the 2010 ACR/EULAR criteria were examined and had their medical histories reviewed. Disease activity was assessed with the DAS28 CRP score. The patients’ characteristics are reported as percentages or as means and standard deviations. The NLR, PLR, SIII, CRP and DAS28 CRP scores were examined using Spearman’s bivariate and multivariate correlations. A significance level of p < 0.05 was set, and SPSS v. 15.0 was used for the analysis

Results: The study included 99.0% Mestizo RA patients, 88.4% (168) of them being women. The patients’ average age was 59.8 years (12.2), and their average disease duration was 18.38 years (10.32). Corticosteroids were used by 77.9% of the patients, while 95.3% (181) used synthetic DMARDs, and 19.5% (37) used biological DMARDs. Significant associations were observed between NLR and CRP (coefficient of 0.69), NLR and DAS28 CRP (0.66), PLR and CRP (0.43), and PLR and DAS28 CRP (0.46); correlations between SIII and DAS28 CRP (0.57) and SIII and CRP(0.61), were also significant ( all with p< 0.001).

Conclusion: The correlations between NLR, PLR and SIII with CRP and DAS28 CRP were found to be significant. These findings highlight the importance of these  biomarkers to assess disease activity in regions of the world like Latin America where resources are limited.

Supporting image 1

Supporting image 2


Disclosures: Y. Velarde Mejia: None; V. Mejia: None; g. velarde: None; G. Alarcon: None.

To cite this abstract in AMA style:

Velarde Mejia Y, Mejia V, velarde g, Alarcon G. Usefulness of the Neutrophil-to-Lymphocyte Ratio, the Platelet-to-Lymphocyte Ratio and the Systemic Immune Inflammatory Index in Assessing Disease Activity in Rheumatoid Arthritis Patients [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/usefulness-of-the-neutrophil-to-lymphocyte-ratio-the-platelet-to-lymphocyte-ratio-and-the-systemic-immune-inflammatory-index-in-assessing-disease-activity-in-rheumatoid-arthritis-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/usefulness-of-the-neutrophil-to-lymphocyte-ratio-the-platelet-to-lymphocyte-ratio-and-the-systemic-immune-inflammatory-index-in-assessing-disease-activity-in-rheumatoid-arthritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology